This statistic depicts the percentage of medtech and biopharma firms that are likely to move existing manufacturing facilities or develop new manufacturing facilities in the U.S. due to the tax reform, according to a survey conducted during summer 2018. According to the survey, 48 percent of companies are likely to build new manufacturing facilities in the U.S. at that time.
Percentage of biopharma and medtech companies that are likely to have manufacturing facilities located in the U.S. due to tax reform as of 2018
Original question: "Has U.S. tax reform increased or decreased the likelihood your company will move existing manufacturing facilities back to the United States or locate a new manufacturing facilities in the United States?"
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Deloitte. (October 26, 2018). Percentage of biopharma and medtech companies that are likely to have manufacturing facilities located in the U.S. due to tax reform as of 2018 [Graph]. In Statista. Retrieved December 03, 2024, from https://www.statista.com/statistics/954628/manufacturing-development-us-life-sciences-companies/
Deloitte. "Percentage of biopharma and medtech companies that are likely to have manufacturing facilities located in the U.S. due to tax reform as of 2018." Chart. October 26, 2018. Statista. Accessed December 03, 2024. https://www.statista.com/statistics/954628/manufacturing-development-us-life-sciences-companies/
Deloitte. (2018). Percentage of biopharma and medtech companies that are likely to have manufacturing facilities located in the U.S. due to tax reform as of 2018. Statista. Statista Inc.. Accessed: December 03, 2024. https://www.statista.com/statistics/954628/manufacturing-development-us-life-sciences-companies/
Deloitte. "Percentage of Biopharma and Medtech Companies That Are Likely to Have Manufacturing Facilities Located in The U.S. Due to Tax Reform as of 2018." Statista, Statista Inc., 26 Oct 2018, https://www.statista.com/statistics/954628/manufacturing-development-us-life-sciences-companies/
Deloitte, Percentage of biopharma and medtech companies that are likely to have manufacturing facilities located in the U.S. due to tax reform as of 2018 Statista, https://www.statista.com/statistics/954628/manufacturing-development-us-life-sciences-companies/ (last visited December 03, 2024)
Percentage of biopharma and medtech companies that are likely to have manufacturing facilities located in the U.S. due to tax reform as of 2018 [Graph], Deloitte, October 26, 2018. [Online]. Available: https://www.statista.com/statistics/954628/manufacturing-development-us-life-sciences-companies/
